| Literature DB >> 29379757 |
Lucas M Mantovani1,2, João P Machado-de-Sousa3, João V Salgado1,2,4.
Abstract
The UCSD Performance-based Skills Assessment (UPSA) is a measure of Functional Capacity and assesses skills involved in community tasks. It has good psychometrics properties, and is currently recommended as a co-primary assessment of cognition in the MATRICS Project. To our knowledge so far, there are no studies in western developing countries concerning Functional Capacity in Schizophrenia. The aims of this study were to translate, culturally adapt and validate the UPSA to assess Functional Capacity in community-dwelling patients with Schizophrenia living in Brazil. Eighty-two subjects (52 patients, 30 controls) were evaluated using: the Brazilian version of the UPSA (UPSA-1-BR), PANSS, Personal and Social Performance (PSP) and Global Assessment of Functioning (GAF). In the reliability test, UPSA-1-BR showed good Internal Consistency (Cronbach's alpha of 0.88) and strong correlation between test and retest (4-month gap; r = 0.91; p < 0.01). Spearman's rho values showed a moderate correlation between UPSA-1-BR and both PSP (0.50; p < 0.01) and GAF (0.46; p < 0.01) scores. UPSA-1-BR is capable of differentiating people with and without Schizophrenia. Patients scored lower than controls (58.9 versus 79.1), with an AUC of 0.79 (95%IC: 0.69-0.89). Sensitivity and specificity values of 0.71 and 0.70, respectively, were found in the cut-off point of 73.5, for separation of patients and controls, with predictive values of 80% (positive) and 58% (negative). UPSA-B-BR was also evaluated. UPSA-1-BR and its brief version presented adequate psychometric properties and proved to be valid and reliable instruments in the assessment of Functional Capacity in subjects with Schizophrenia.Entities:
Keywords: Everyday functioning; Functional capacity; Schizophrenia; Transcultural validation; UPSA
Year: 2015 PMID: 29379757 PMCID: PMC5779289 DOI: 10.1016/j.scog.2014.12.002
Source DB: PubMed Journal: Schizophr Res Cogn ISSN: 2215-0013
Demographic, clinical and real-world functioning scores for patients and controls.
| Patients | Controls | Statistical test | ||
|---|---|---|---|---|
| Mean age (sd) | 42 (12.3) | 39.3 (8.0) | 1.2 | 0.227 |
| Gender, males [n (%)] | 33 (63.5) | 6 (20.0) | 14.4 | 0.000 |
| Parenthood, parent [n (%)] | 15 (28.8) | 28 (93.3) | 31.7 | 0.000 |
| Education (yrs), mean (sd) | 7.6 (3.4) | 8.9 (2.6) | 586.5 | 0.058 |
| Marital status [n (%)] | 162.7 | 0.000 | ||
| Single | 36 (69.2) | 2 (6.7) | ||
| Married | 13 (25) | 20 (66.7) | ||
| Cohabitation | 0 (0.0) | 6 (20.0) | ||
| Divorced | 3 (5.8) | 2 (6.7) | ||
| Work Status [n (%)] | 120.3 | 0.000 | ||
| Not working | 27 (51.9) | 8 (26.7)) | ||
| Working | 6 (11.5) | 21 (70.0) | ||
| Retired | 3 (5.8) | 1 (3.3) | ||
| Permanently Disabled due to mental illness | 16 (30.8) | 0 (0.0) | ||
| PANSS [mean (sd)] | ||||
| Positive | 9.1 (2.6) | |||
| Negative | 18.8 (6.9) | |||
| General Psychopathology | 24.3 (6.4) | |||
| Total | 51.8 (13) | |||
| Anti-psychotics class, atypicals [n (%)] | 19 (36.5) | |||
| Anti-psychotics dose, Chlorp. Eq. [mean (sd)] | 304.2 (200.5) | |||
| GAF [Mean (sd)] | 63.7 (15.0) | 95.2 (6.6) | 13.0 | 0.000 |
| PSP total score [Mean (sd)] | 63.7 (14.7) | 94.9 (6.6) | 17.0 | 0.000 |
n: subjects; sd: standard deviation; yrs: years; Chlorp. Eq.: Chlorpromazine Equivalent; PANSS: Positive and Negative Syndrome Scale; GAF: Global Assessment of Functioning; PSP: Personal and Social Performance Scale.
Student’s t test.
Chi-square test.
Mann–Whitney test.
Not working included: unemployed, temporarily disabled.
Distribution profile of UPSA-1-BR and UPSA-B-BR for patients and controls.
| Patients | Controls | Student test, | ||
|---|---|---|---|---|
| Planning recreational activities [Mean (sd)] | 13.4 (4.0) | 16.5 (3.4) | − 3.6 | 0.001 |
| Finances [Mean (sd)] | 10.3 (5.5) | 15.1 (3.9) | − 4.7 | 0.000 |
| Communication [Mean (sd)] | 9.3 (4.7) | 14.0 (3.9) | − 4.7 | 0.000 |
| Transportation [Mean (sd)] | 14.0 (5.8) | 16.4 (4.3) | − 2.0 | 0.048 |
| Household [Mean (sd)] | 11.9 (7.7) | 17.0 (3.1) | − 4.2 | 0.000 |
| UPSA-1-BR Total Score [Mean (sd)] | 58.9 (21.3) | 79.1 (13.7) | − 5.2 | 0.000 |
| Coefficient of Variance (%) | 36.2 | 17.3 | ||
| Skewness (se) | -.61 (.33) | -.82 (.43) | ||
| Kurtosis (se) | -.10 (.65) | .43 (.83) | ||
| Ceiling effect | - | 2 (6.7) | ||
| Floor effect | 0 (0.0) | - | ||
| UPSA-B-BR Total Score [Mean (sd)] | 49.1 (22.1) | 73.1 (16.9) | − 5.1 | 0.000 |
| Coefficient of Variance (%) | 45.0 | 23.1 | ||
| Skewness (se) | -.09 (.33) | -.52 (.43) | ||
| Kurtosis (se) | -.38 (.65) | -.43 (.83) | ||
| Ceiling effect | - | 1 (3.3) | ||
| Floor effect | 1 (1.9) | - |
n: subjects; sd: standard deviation; se: standard error.
Number (%) of controls with scores greater than 95%.
Number (%) of patients with scores lower than 5%.
Reliability of the UPSA-1-BR and the UPSA-B-BR.
| UPSA-1-BR Domains | Internal Consistency | Test–Retest | |
|---|---|---|---|
| Patients | Controls | ||
| Planning recreational activities | 0.76 | 0.75 | 0.52 |
| Finances | 0.71 | 0.62 | 0.79 |
| Communication | 0.61 | 0.46 | 0.89 |
| Transportation | 0.71 | 0.58 | 0.59 |
| Household | 0.81 | − 0.37 | 0.75 |
| UPSA-1-BR Total Score | 0.88 | 0.84 | 0.91 |
| UPSA-B-BR Total Score | 0.78 | 0.70 | 0.88 |
⁎p < 0.05.
Cronbach’s alpha at item level.
Pearson Correlation Coefficient, with a mean test-retest interval of 120 days, in patients.
p < 0.01.
Fig. 1Total UPSA-1-BR and UPSA-B-BR ROC Curves for Schizophrenia.